iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
67 hedge funds and large institutions have $47.9M invested in iShares Genomics Immunology and Healthcare ETF in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
73% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 11
Holders
67
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.3M | |
| 2 | +$814K | |
| 3 | +$784K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$587K |
| 5 |
PCA
Pallas Capital Advisors
Braintree,
Massachusetts
|
+$428K |
Top Sellers
| 1 | -$1.03M | |
| 2 | -$964K | |
| 3 | -$465K | |
| 4 |
LPL Financial
San Diego,
California
|
-$382K |
| 5 |
AWM
Apollon Wealth Management
Mount Pleasant,
South Carolina
|
-$371K |